Study of the analgesic effects of repeated doses of F13640 in spinal cord injury patients with moderate to severe central neuropathic pain. A multinational, multicenter, randomized, double blind, parallel groups, placebo-controlled study.
Study of the analgesic effects of repeated doses of F13640 in spinal cord injury patients with moderate to severe central neuropathic pain. A multinational, multicenter, randomized, double blind, parallel groups, placebo-controlled study.
Study of the analgesic effects of repeated doses of F13640 in spinal cord injury patients with moderate to severe central neuropathic pain. A multinational, multicenter, randomized, double blind, parallel groups, placebo-controlled study.
Statut
Status :
Terminé
Type d'étude
Phase II
Age Min.
18
Ans
Age Max.
65
Ans
Genre
Tous
Aire thérapeutique :
Système nerveux central
Maladie :
Neuropathie
Traitement :
F13640
Phase :
Phase II
Date de début de l'étude :
19 Février 2008
End date :
03 Décembre 2008
Identifiant de l'essai :
F13640 GE 210
Identifiant EudraCT/CTIS :
2007-003230-42
Envoyer par email